Adenovirus-based targeting in myoblasts is hampered by nonhomologous vector integration

Human Gene Therapy

Volumn 19, Issue 10, 2008, Pages 1000-1008

  Isman, Olga ^a,b   Roberts, Michael L ^a,c   Morgan, Jennifer E ^b,d   Graham, Ian R ^a   Goldring, Kirstin ^b   Lawrence Watt, Diana J ^b,e   Lu, Qi Long ^b,f   Dunckley, Matthew G ^a,g   Porter, Andrew C G ^b   Partridge, Terence A ^b,h   Dickson, George ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Regulon   (Greece)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^f CAROLINAS MEDICAL CENTER   (United States)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^h CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DYSTROPHIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DNA INTEGRATION; DNA REPLICATION; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE CONSTRUCT; GENE LOCUS; GENE MUTATION; GENE TARGETING; INTRON; MALE; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY;

ADENOVIRIDAE; ANIMALS; DERMIS; DNA REPLICATION; DYSTROPHIN; EMBRYONIC STEM CELLS; FIBROBLASTS; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; MYOBLASTS; QUANTITATIVE TRAIT LOCI; VIRUS INTEGRATION;

ADENOVIRIDAE; MUS;

EID: 54949129823     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.063     Document Type: Article

References (28)

1. Alter, J., Lou, F., Rabinowitz, A., Yin, H., Rosenfeld, J., Wilton, S.D., Partridge, T.A., and Lu, Q.L. (2006). Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat. Med. 12, 175-177.
2. Arechavala-Gomeza, V., Graham, I.R., Popplewell, L.J., Adams, A.M., Aartsma-Rus, A., Kinali, M., Morgan, J.E., van Deutekom, J.C., Wilton, S.D., Dickson, G., and Muntoni, F. (2007). Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Hum. Gene Ther. 18, 798-810.
3. Arnould, S., Perez, C., Cabaniols, J.P., Smith, J., Gouble, A., Grizot, S., Epinat, J.C., Duclert, A., Duchateau, P., and Paques, F. (2007). Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells. J. Mol. Biol. 371, 49-65.
4. -/- mouse model for Duchenne muscular dystrophy. Regen. Med. 2, 275-288.
5. Bertoni, C., Morris, G.E., and Rando, T.A. (2005). Strand bias in oligonucleotide-mediated dystrophin gene editing. Hum. Mol. Genet. 14, 221-233.
6. Bett, A.J., Haddara, W., Prevec, L., and Graham, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. U.S.A. 91, 8802-8806.
7. Chamberlain, J.R., Schwarze, U., Wang, P.R., Hirata, R.K., Hankenson, K.D., Pace, J.M., Underwood, R.A., Song, K.M., Sussman, M., Byers, P.H., and Russell, D.W. (2004). Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303, 1198-1201.
8. Cheon, S.S., Wei, Q., Gurung, A., Youn, A., Bright, T., Poon, R., Whetstone, H., Guha, A., and Alman, B.A. (2006). β-Catenin regulates wound size and mediates the effect of TGF-β in cutaneous healing. FASEB J. 20, 692-701.
9. Gibson, A.J., Karasinski, J., Relvas, J., Moss, J., Sherratt, T.G., Strong, P.N., and Watt, D.J. (1995). Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle. J. Cell Sci. 108, 207-214.
10. Gregorevic, P., Blankinship, M.J., Allen, J.M., Crawford, R.W., Meuse, L., Miller, D.G., Russell, D.W., and Chamberlain, J.S. (2004). Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 10, 828-834.
11. Harui, A., Suzuki, S., Kochanek, S., and Mitani, K. (1999). Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73, 6141-6146.
12. Inagaki, K., Fuess, S., Storm, T.A., Gibson, G.A., McTiernan, C.F., Kay, M.A., and Nakai, H. (2006). Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14, 45-53.
13. Jat, P.S., Noble, M.D., Ataliotis, P., Tanaka, Y., Yannoutsos, N., Larsen, L., and Kioussis, D. (1991). Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. U.S.A. 88, 5096-5100.
14. Kapsa, R.M., Quigley, A.F., Vadolas, J., Steeper, K., Ioannou, P.A., Byrne, E., and Kornberg, A.J. (2002). Targeted gene correction in the mdx mouse using short DNA fragments: Towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle. Gene Ther. 9, 695-699.
15. Mitani, K., Wakamiya, M., Hasty, P., Graham, F.L., Bradley, A., and Caskey, C.T. (1995). Gene targeting in mouse embryonic stem cells with an adenoviral vector. Somat. Cell Mol. Genet. 21, 221-231.
16. Morgan, J.E., Beauchamp, J.R., Pagel, C.N., Peckham, M., Ataliotis, P., Jat, P.S., Noble, M.D., Farmer, K., and Partridge, T.A. (1994). Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: A model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162, 486-498.
17. Morosetti, R., Mirabella, M., Gliubizzi, C., Broccolini, A., Sancricca, C., Pescatori, M., Gidaro, T., Tasca, G., Frusciante, R., Tonali, P.A., Cossu, G., and Ricci, E. (2007). Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells 25, 3173-3182
18. Ohbayashi, F., Balamotis, M.A., Kishimoto, A., Aizawa, E., Diaz, A., Hasty, P., Graham, F.L., Caskey, C.T., and Mitani, K. (2005). Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors. Proc. Natl. Acad. Sci. U.S.A. 102, 13628-13633.
19. Rando, T.A., Disatnik, M.H., and Zhou, L.Z. (2000). Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 97, 5363-5368.
20. Sampaolesi, M., Torrente, Y., Innocenzi, A., Tonlorenzi, R., D'Antona, G., Pellegrino, M.A., Barresi, R., Bresolin, N., De Angelis, M.G., Campbell, K.P., Bottinelli, R., and Cossu, G. (2003). Cell therapy of α-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301, 487-492.
21. Sampaolesi, M., Blot, S., D'Antona, G., Granger, N., Tonlorenzi, R., Innocenzi, A., Mognol, P., Thibaud, J.L., Galvez, B.G., Barthelemy, I., Perani, L., Mantero, S., Guttinger, M., Pansarasa, O., Rinaldi, C., Cusella de Angelis, M.G., Torrente, Y., Bordignon, C., Bottinelli, R., and Cossu, G. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444, 574-579.
22. Thomas, K.R. and Capecchi, M.R. (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
23. Todaro, M., Quigley, A., Kita, M., Chin, J., Lowes, K., Kornberg, A.J., Cook, M.J., and Kapsa, R. (2007). Effective detection of corrected dystrophin loci in mdx mouse myogenic precursors. Hum. Mutat. 28, 816-823.
24. Urnov, F.D., Miller, J.C., Lee, Y.L., Beausejour, C.M., Rock, J.M., Augustus, S., Jamieson, A.C., Porteus, M.H., Gregory, P.D., and Holmes, M.C. (2005). Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435, 646-651.
25. van Deutekom, J.C., Janson, A.A., Ginjaar, I.B., Frankhuizen, W.S., Aartsma-Rus, A., Bremmer-Bout, M., den Dunnen, J.T., Koop, K., van der Kooi, A.J., Goemans, N.M., de Kimpe, S.J., Ekhart, P.F., Venneker, E.H., Platenburg, G.J., Verschuuren, J.J., and van Ommen, G.J. (2007). Local dystrophin restoration with antisense oligonucleotide PRO051. N. Engl. J. Med. 357, 2677-2686.
26. Wang, Z., Zhu, T., Qiao, C., Zhou, L., Wang, B., Zhang, J., Chen, C., Li, J., and Xiao, X. (2005). Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23, 321-328.
27. Wang, Z., Kuhr, C.S., Allen, J.M., Blankinship, M., Gregorevic, P., Chamberlain, J.S., Tapscott, S.J., and Storb, R. (2007). Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Mol. Ther. 15, 1160-1166.
28. Yasuoka, H., Jukic, D.M., Zhou, Z., Choi, A.M., and Feghali-Bostwick, C.A. (2006). Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis. Arthritis Rheum. 54, 3001-3010.